Company profile
Definium Therapeutics
Precise science. Boundless impact.
- Industry
- Biotechnology Research
- Employees
- 142
- Headquarters
- New York, NY
- Founded
- 2019
- LinkedIn followers
- 43,370
- Office locations
- 1
Definium Therapeutics company summary
Definium Therapeutics is a company in the Biotechnology Research industry, headquartered in New York, NY, founded in 2019. On LinkedIn the company has around 142 employees and 43,370 followers.
What technology does Definium Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Definium Therapeutics
Definium Therapeutics (formerly MindMed) is a biotech company forging a new era of psychiatry by applying precision to psychedelic medicine. We develop science-led, accessible treatment approaches designed to open new routes for brain health and help people reclaim more vibrant lives. From day one, we have been powered by a radical idea: treatments for anxiety and depression should bring real relief. Together we’re moving psychiatry forward— beyond better, into a boundless future. Definium Therapeutics trades on the NASDAQ under the symbol DFTX.
Where is Definium Therapeutics located?
Definium Therapeutics lists 1 location.
Compare companies similar to Definium Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Definium Therapeutics definiumtx.com | Biotechnology Research | 142 | 2019 | New York, NY |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Definium Therapeutics
What does Definium Therapeutics do?
Definium Therapeutics (formerly MindMed) is a biotech company forging a new era of psychiatry by applying precision to psychedelic medicine. We develop science-led, accessible treatment approaches designed to open new routes for brain health and help people reclaim more vibrant lives. From day one, we have been powered by a radical idea: treatments for anxiety and depression should bring real relief. Together we’re moving psychiatry forward— beyond better, into a boundless future. Definium Therapeutics trades on the NASDAQ under the symbol DFTX.
How many employees does Definium Therapeutics have?
Definium Therapeutics has around 142 employees on LinkedIn.
Where is Definium Therapeutics headquartered?
Definium Therapeutics is headquartered in New York, NY.
When was Definium Therapeutics founded?
Definium Therapeutics was founded in 2019.
Build a lead list from companies like Definium Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.